FDA conditionally approves drug for canine neuropathic painMay 13, 2026Liavium-CA1 is indicated for the management of pain and clinical signs associated with Chiari-like malformation and syringomyelia in dogs. The drug, with the active ingredient pregabalin, reduces the release of neurotransmitters that send pain signals in the spinal cord.
SPONSORED CONTENTHill's Prescription Diet Metabolic Weight + j/dNutrition to help fight inflammation and preserve cartilage. 88% of pets lost weight in 2 months at home when fed Metabolic nutrition. + Learn More
